Cause for a re- think on drug models of psychosis and other psychiatric disorders

Psychiatry’s next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders RL Carhart-Harris, S Brugger, DJ Nutt and JM Stone Despite the widespread application of drug modelling in psychiatric research, the relative value of different models has never been formally compared in the same analysis. Here we compared the …

Read moreCause for a re- think on drug models of psychosis and other psychiatric disorders

A web based survey on mephedrone

A web-based survey on mephedrone Mephedrone (4-methylmethcathinone) is a substituted cathinone with stimulant properties. The popularity of mephedrone in the UK rose sharply in 2009 after it became seen as a legal, cheap and easily available alternative to MDMA (ecstasy). Adverse events associated with its use, including a series of alleged deaths, attracted media attention …

Read moreA web based survey on mephedrone

Relative Harms and Benefits of Drugs

Experienced Drug Users Assess the Relative Harms and Benefits of Drugs: A Web-Based Survey   A web-based survey was used to consult the opinions of experienced drug users on matters related to drug harms. We identified a rare sample of 93 drug users with personal experience with 11 different illicit drugs that are widely used …

Read moreRelative Harms and Benefits of Drugs

LSD cures depression? Scientists plead for cash to fund ‘exciting’ drug study

To date, the project has been partially funded by Imperial College London and the Beckley Foundation. However, researchers are now in need of £25,000 to analyze scans.

Scientists belief LSD (lysergic acid diethylamide) can be used to treat addictions, depression and chronic pain.

So far, 20 healthy volunteers, including 15 men and 5 women, were injected with 75 microgram of LSD. Their brain activity was then scanned to review the effects.